$15 Million for Calimmune and California Stem Cell HIV Trial
By David Jensen,
California Stem Cell Report
| 05. 27. 2015
Untitled Document
Calimmune, Inc., which has received $8.3 million from the California stem cell agency, today announced it has rustled up another $15 million to help out with the work that the agency is backing.
Calimmune of Tucson, Ariz., was co-founded by a former agency board member and Nobel Prize winner David Baltimore. It is currently engaged in a clinical trial in Los Angeles and San Francisco involving a treatment for HIV.
“Calimmune hasn't had much of a profile outside of the HIV world, but (CEO Louis) Breton is looking to change that. The company has a staff of 40 now, he says, and is looking to expand and possibly strike a partnership deal with a Big Pharma in the space. And unlike some of the leading gene therapy companies in the industry which are targeting tiny populations, Calimmune is tackling a treatment for a disease with a huge, global population of patients. Discussions about million-dollar therapies, he says, won't work for something like HIV.
"‘Our mission,’ says Breton...
Related Articles
By Annalee Armstrong, BioSpace | 09.11.2024
Complex gene therapies are starting to hit the market but all have faced the same reality: a tepid reception from the healthcare system and a cloudy path to profitability.
It can take about a year for a patient to go...
By Matthew Rozsa, Salon | 09.15.2024
When a person with a uterus decides to freeze their eggs, any number of things can go wrong. Ice crystal can form, killing an otherwise viable ovum. A fertilized egg may fail to properly implant, or the egg may...
By Sarah Kliff, The New York Times | 09.09.2024
Image by Stephen Andrews from Unsplash
Yale agreed on Monday to pay dozens of patients who had filed lawsuits claiming that they had endured excruciatingly painful egg retrieval procedures after a nurse at its fertility clinic secretly swapped their anesthesia...
By Ari Schulman, The New York Times | 09.09.2024
There was immediate backlash when Alabama’s Supreme Court ruled in February that embryos created through in vitro fertilization qualified as children under the state’s wrongful death law. But it was a backlash as much from the right as from the...